Commentary|Videos|November 19, 2026

ESMO and EONS 2026: Workforce and Therapy Takeaways for Oncology Nurses

Fact checked by: Alex Biese

An ONS nursing practice leader shares takeaways from EONS19 at ESMO 2026, from workforce sustainability to new therapies and subcutaneous care.

Oncology nurses in the United States and Europe face far more shared challenges than differences, from workforce sustainability to the growing complexity of cancer therapies, according to Kathleen Wiley, MSN, RN, AOCNS, director of oncology nursing practice at the Oncology Nursing Society (ONS).

Wiley presented at the 19th Congress of the European Oncology Nursing Society (EONS19), held during the ESMO Congress 2026 in Madrid, Spain, and noted that the effect of new formulations on nursing workload remains unclear.

What was the focus of EONS19?

EONS19 was held October 24 to 26, 2026, under the theme “Equitable and Sustainable Care: The Ever-Evolving Cancer Nursing Workforce.”1 “The conference was heavily themed around sustaining oncology nursing workforce and the best way to future proof the profession,” Wiley said in an interview with Oncology Nursing News.

She said sessions examined what puts nurses at risk for burnout and how to prepare the workforce for an anticipated growth in the number of people living with cancer.

How do challenges compare between the US and Europe?

“Cancer and its treatment, the stress it puts on patients and therefore the nurses are really the same, both in the US and in Europe,” Wiley said. She noted that both regions are investing in foundational orientation programs, competencies that help newer nurses feel supported, and access to professional development.

Both are also urging nurses to engage in advocacy. Directing efforts toward “meaningful change for the patients you serve is really fulfilling and gratifying,” she said.

One difference stood out. “I was struck by the emphasis that EONS put on their efforts on mentorship programs for their members,” Wiley said, describing initiatives that link members to discuss practice issues and challenges.

How are new therapies affecting nursing workload?

Wiley said the pace of change in oncology adds to burnout and staffing pressure. “The therapies and now even routes of administration are changing at an extraordinarily fast pace,” she said. “Nurses want to do right by their patients. They're not going to delay a patient getting a therapy because they themselves aren't necessarily familiar with it.”

She called on leadership to provide education on novel therapies and protected time for professional development, to give nurses a role in bringing new therapies into administration areas, and to ensure access to point-of-care resources. Wiley added that EONS sessions explained the pharmacology and toxicities of bispecific antibodies and antibody-drug conjugates “in a very practical way.”

What role will subcutaneous administration play?

Subcutaneous formulations were another major takeaway, and Wiley highlighted their benefits for patients. However, she cautioned that operational gains for nurses are not guaranteed. “While there was an expectation that this may positively impact the workflow for nurses and provide more time for them, that piece remains to be seen,” she said.

Recent approvals, such as an on-body injector for subcutaneous isatuximab-irfc (Sarclisa Escena), are already changing workflows,2 and nurses administering lengthy manual injections have described strategies to avoid exhaustion and soreness.3

What are the key takeaways for oncology nurses?

  • Workforce sustainability and burnout prevention were central themes at EONS19.
  • US and European oncology nurses share similar pressures, orientation priorities, and interest in advocacy; EONS places notable emphasis on mentorship.
  • Rapidly changing therapies and routes of administration add to nurse workload, making protected education time and point-of-care resources essential.
  • The workflow benefits of subcutaneous administration for nurses have yet to be established.

References

1. EONS19 - Equitable and sustainable care: the ever-evolving cancer nursing workforce. European Oncology Nursing Society. Accessed November 9, 2026. https://www.cancernurse.eu/event/eons19-equitable-and-sustainable-care-the-ever-evolving-cancer-nursing-workforce-3

2. Biese A. On-body injectors: what oncology nurses and PAs need to know. Oncology Nursing News. October 14, 2026. Accessed November 9, 2026. https://www.oncnursingnews.com/view/on-body-injectors-what-oncology-nurses-and-pas-need-to-know

3. Hoyt B. Q&A: avoiding exhaustion, soreness during subcutaneous injections. Oncology Nursing News. May 28, 2025. Accessed November 9, 2026. https://www.oncnursingnews.com/view/q-a-avoiding-exhaustion-soreness-during-subcutaneous-injections


Related to this article